{"id":53207,"date":"2023-01-23T23:02:35","date_gmt":"2023-01-23T22:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/"},"modified":"2023-01-23T23:02:35","modified_gmt":"2023-01-23T22:02:35","slug":"fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/","title":{"rendered":"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023"},"content":{"rendered":"<div>\n<p>BANGKOK&#8211;(BUSINESS WIRE)&#8211;Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced it will release its second quarter fiscal year 2023 financial results for the period ended December 30, 2022 after market close on Monday, February 6, 2023. On that day, management will hold a conference call and webcast at 5:00 p.m. ET to review and discuss the Company\u2019s results.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/4\/fabrinet.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/21\/fabrinet.jpg\"><\/a><\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWhat:\n<\/p>\n<\/td>\n<td class=\"bwtablemarginb bwblockalignl\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nFabrinet Second Quarter Fiscal Year 2023 Financial Results Call\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWhen:\n<\/p>\n<\/td>\n<td class=\"bwtablemarginb bwblockalignl\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nMonday, February 6, 2023\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTime:\n<\/p>\n<\/td>\n<td class=\"bwtablemarginb bwblockalignl\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n5:00 p.m. ET\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nLive Call\n<\/p>\n<\/td>\n<td class=\"bwtablemarginb bwblockalignl\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n&amp; Replay:\n<\/p>\n<\/td>\n<td class=\"bwtablemarginb bwblockalignl\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.fabrinet.com%2Fevents-and-presentations%2Fevents&amp;esheet=53285538&amp;newsitemid=20230123005076&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestor.fabrinet.com%2Fevents-and-presentations%2Fevents&amp;index=1&amp;md5=755be2af95f7b168cf73c4a76887c6e4\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/investor.fabrinet.com\/events-and-presentations\/events<\/a>\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nA recorded version of this webcast will be available approximately two hours after the call and also accessible at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.fabrinet.com%2F&amp;esheet=53285538&amp;newsitemid=20230123005076&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestor.fabrinet.com%2F&amp;index=2&amp;md5=87bebc34b76c32f4cc942dfdbe02019b\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/investor.fabrinet.com\/<\/a>. The webcast will be archived on Fabrinet\u2019s website for a period of one year.\n<\/p>\n<p>\n<b>About Fabrinet<\/b>\n<\/p>\n<p>\nFabrinet is a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and subsystems, automotive components, medical devices, industrial lasers and sensors. Fabrinet offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, advanced packaging, integration, final assembly and testing. Fabrinet focuses on production of high complexity products in any mix and any volume. Fabrinet maintains engineering and manufacturing resources and facilities in Thailand, the United States of America, the People\u2019s Republic of China, Israel and the United Kingdom. For more information visit: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fabrinet.com%2F&amp;esheet=53285538&amp;newsitemid=20230123005076&amp;lan=en-US&amp;anchor=www.fabrinet.com&amp;index=3&amp;md5=d5ab5e383efb2dbce0ccf1bab3cb1d3c\" rel=\"nofollow noopener\" shape=\"rect\">www.fabrinet.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact:<\/b><br \/>Garo Toomajanian<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;i&#x72;&#64;f&#x61;&#98;&#x72;&#x69;n&#x65;&#116;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x72;&#x40;f&#97;&#x62;r&#105;&#x6e;&#x65;t&#46;&#x63;o&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BANGKOK&#8211;(BUSINESS WIRE)&#8211;Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced it will release its second quarter fiscal year 2023 financial results for the period ended December 30, 2022 after market close on Monday, February 6, 2023. On &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53207","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BANGKOK&#8211;(BUSINESS WIRE)&#8211;Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced it will release its second quarter fiscal year 2023 financial results for the period ended December 30, 2022 after market close on Monday, February 6, 2023. On ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-23T22:02:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/21\/fabrinet.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023\",\"datePublished\":\"2023-01-23T22:02:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/\"},\"wordCount\":276,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005076\\\/en\\\/1690060\\\/21\\\/fabrinet.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/\",\"name\":\"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005076\\\/en\\\/1690060\\\/21\\\/fabrinet.jpg\",\"datePublished\":\"2023-01-23T22:02:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005076\\\/en\\\/1690060\\\/21\\\/fabrinet.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230123005076\\\/en\\\/1690060\\\/21\\\/fabrinet.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/","og_locale":"en_US","og_type":"article","og_title":"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023 - Pharma Trend","og_description":"BANGKOK&#8211;(BUSINESS WIRE)&#8211;Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced it will release its second quarter fiscal year 2023 financial results for the period ended December 30, 2022 after market close on Monday, February 6, 2023. On ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-23T22:02:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/21\/fabrinet.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023","datePublished":"2023-01-23T22:02:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/"},"wordCount":276,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/21\/fabrinet.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/","url":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/","name":"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/21\/fabrinet.jpg","datePublished":"2023-01-23T22:02:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/21\/fabrinet.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230123005076\/en\/1690060\/21\/fabrinet.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/fabrinet-to-announce-second-quarter-2023-financial-results-on-february-6-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Fabrinet to Announce Second Quarter 2023 Financial Results on February 6, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53207"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53207\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}